MedTrace Logo

Effectiveness of Six Sessions CBT for Adolescents With Emotional Problems in Community Clinics

NCT02150265 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 163

Last updated 2019-05-23

No results posted yet for this study

Summary

Background: There is need for more effectiveness studies concerning treatment of emotional symptom problems indicating anxiety and depression in adolescents. SMART is the only treatment manual for combined emotional disorders developed in Norwegian.

Purpose: To find the best individualized treatment for adolescents with emotional difficulties by: Finding criteria for the selection of appropriate patients for treatment with cognitive-behavior therapy program SMART in an outpatient population (14-18 years). Finding predictors of completion of treatment program SMART. Examining the effects of treatment with the SMART program at 6 months follow-up.

Design: A randomized controlled study in six outpatient clinics in the north of Norway. N= 160 referred adolescents (14-18 years) with score above 6 on the Emotional Problems scale of the Strength and Difficulties Questionnaire (SDQ). Two thirds are treated according to the SMART-manual immediately, while the waiting list control group is treated with SMART after six weeks.

Hypothesis: The SMART treatment is an effective treatment for emotional symptom problems.

Publication: The results sought published internationally and nationally and will be communicated to clinicians.

Conditions

  • Generalized Anxiety Disorder
  • Social Phobia
  • Agoraphobia
  • Depression
  • Panic Disorder

Interventions

BEHAVIORAL

SMART manual cognitive behavioral therapy

Sponsors & Collaborators

  • The Royal Norwegian Ministry of Health

    collaborator OTHER

  • Regionsenter for barn og unges psykiske helse

    collaborator OTHER

  • University of Tromso

    lead OTHER

Principal Investigators

  • Ingunn Skre, PhD · UiT Arctic University of Norway

  • Simon-Peter Neumer, Dr philos · Regionsenter for barn og unges psykiske helse, Sør-Øst

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
14 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-01
Primary Completion
2017-06-30
Completion
2018-03-01

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02150265 on ClinicalTrials.gov